Testoviron-Depot (Testosterone)

Quick links

Choose a section

Quick links to important sections

Advertisements

Testoviron-Depot (Testosterone)

Advertisements
Advertisements

Treatment option: Hypogonadism

Advertisements

Overview of Testoviron-Depot (Testosterone)

Property Description
Active Ingredient Testosterone enanthate
Form Oily Solution for Injection (Depot)
Pharmacological Class Androgen, Anabolic steroid
General Purpose Hormone replacement (to restore balance)
Origin Synthetic androgen ester

Testoviron-Depot: Definition and Classification as an Androgen Ester

Testoviron-Depot is a prescription-only medicine whose active component is testosterone enanthate, a synthetic derivative of the naturally occurring male sex hormone (androgen). It is classified pharmacologically as an androgen and an anabolic steroid. The drug functions as an exogenous androgen to provide replacement or supplementary testosterone when an individual has a medically confirmed deficiency of the endogenous hormone. This means the medication supplies the hormone your body needs when it can't make enough itself. Testoviron-Depot is clinically used to address hormonal deficits, and its core function is to act as a replenisher fundamental to hormone replacement therapy (TRT).

Composition, Form, and General Purpose

The medication is administered as a depot injection, supplied as a clear, yellowish oily solution for injection intended for intramuscular (IM) use. As a brand, Testoviron-Depot utilizes testosterone enanthate, an esterified variant dissolved in a specific oil base/vehicle to create a localized "storage pool," or depot, at the injection site. This unique composition enables the slow, sustained release of testosterone into the bloodstream over an extended period. The use of long-acting testosterone esters, such as enanthate, is an established method in hormone replacement due to its consistent pharmacokinetic profile. Using this type of testosterone helps achieve stable hormone levels over time. The fundamental purpose of this sustained-release system is to restore and maintain consistent, stable testosterone levels, which compensates for the hormonal imbalance resulting from a deficiency.

Advertisements

What side effects are possible with Testoviron-Depot (Testosterone)?

Possible Side Effects and Safety Information

This section summarizes the officially documented adverse reactions and safety restrictions for testosterone undecanoate, strictly based on governmental regulatory documents.


Adverse Reactions Scope

Common side effects (reported in 1 to 10 out of 100 users) typically involve changes in blood parameters such as an increase in haemoglobin and haematocrit, acne, various prostatic changes (e.g., benign prostatic hyperplasia), and injection site reactions.

Rare but serious events include the occurrence of benign and malignant liver tumours and pulmonary micro-embolism of oily solutions during or immediately after injection, which may manifest as temporary cough or difficulty breathing.

Other system-organ classes involved include the cardiovascular system (e.g., hypertension, venous thromboembolism), metabolism (e.g., weight gain, fluid retention leading to oedema), and the reproductive system (e.g., priapism, gynaecomastia).


Serious Safety Considerations and Restrictions

Contraindications prohibit use in individuals with known or suspected androgen-dependent carcinoma of the prostate or male mammary gland, existing or past liver tumours, and in women and children under 18 years. Use is also restricted in patients with hypercalcaemia associated with malignant tumours.

High-level caution is required for patients with pre-existing conditions, particularly severe cardiac, hepatic, or renal insufficiency, due to the increased risk of severe oedema and congestive cardiac failure. Regular monitoring of blood parameters, including haemoglobin, haematocrit, and liver enzymes, is necessary throughout treatment. Use in older males requires regular prostate examination due to the risk of prostatic changes. Discontinuation may be necessary if signs of excessive androgen exposure (e.g., persistent or excessively frequent erections) occur.

Advertisements

Overdose and Emergency Response

The official regulatory profile for Testoviron-Depot (Testosterone) overdose states that acute toxicity from a single large dose is generally not expected. The primary concerns arise from prolonged exposure to excessive amounts, which may require immediate medical attention.

Documented Overexposure Signs

Overexposure is officially characterized by clinical symptoms necessitating intervention, including irritability, nervousness, weight gain, and priapism (persistent or frequent erections). High-dosed administration also increases the tendency for water retention and oedema. Due to the oily solution, an acute reaction called pulmonary oil microembolism (POME) may occur at the time of injection, presenting with signs like cough, chest pain, and syncope.

Required Emergency Actions

Regulators mandate that if signs of excessive androgen exposure occur, the dosage must be reduced or the therapy discontinued. Immediate emergency attention is required for severe manifestations:

  • Seek immediate emergency attention for severe abdominal pains (potential sign of liver complication).
  • Life-threatening complications reported with supra-therapeutic abuse include heart attack, stroke, and the development of hepatic neoplasms.

Management of overexposure is entirely symptomatic and supportive, as no specific antidote is known. For POME reactions, supportive measures, such as additional oxygen administration, are officially described. The risk of severe oedema is higher for patients with existing cardiac, hepatic, or renal insufficiency.

Advertisements

Therapeutic Uses of Testoviron-Depot (Testosterone)

Testoviron-Depot, which contains testosterone enanthate, is used in situations involving systemic imbalance linked to testosterone deficiency. The medication is indicated for conditions associated with a confirmed deficiency or absence of testosterone, and may be used for the symptomatic management of systemic or localized discomfort due to hormone deficiency. It is applied across therapeutic domains to manage resulting systemic symptoms and to support physical function and well-being.

It is used to treat male hypogonadism (low testosterone) and helps address symptom clusters that create noticeable interference with daily stability, including low sex drive, chronic fatigue, and depressed mood. Furthermore, it assists with stimulating puberty in adolescent boys with confirmed delayed development, and is relevant across domains where additional symptomatic support is needed, such as in certain hormone-responsive types of mammary cancer in women.


Quick Fact: Relief for Systemic Imbalance

The medication assists with managing symptoms related to systemic imbalance by supporting functional stability, contributing to comfort during symptomatic periods, and helping to maintain muscle bulk and skeletal health.

Regulatory References

  1. DailyMed FDA Label Information
Advertisements

Eligibility and Restrictions for Use

Testoviron-Depot (Testosterone enanthate) eligibility is strictly defined by regulatory documents, distinguishing between approved use, conditional use, and absolute contraindications.

Populations Allowed Use

Population Regulatory Status Restriction
Adult Males Approved/Indicated Only for confirmed testosterone deficiency (Primary or Hypogonadotropic Hypogonadism).
Adolescent Males Conditional Use Allowed only for stimulating delayed puberty, requiring bone age monitoring to prevent premature epiphyseal closure.
Women Conditional Use Restricted to specific conditions, such as certain hormone-responsive mammary cancers, with required monitoring for virilization.

Absolute Contraindications

Use is strictly prohibited for several populations due to severe risks:

  • Men with Carcinoma of the Breast or Known/Suspected Carcinoma of the Prostate.
  • Women who are Pregnant or Breastfeeding (due to risk of fetal virilization).
  • Patients with a Known Hypersensitivity to the active ingredient or excipients.
  • Newborn Infants and Small Children.

Conditional Use and Monitoring

Certain groups require special caution or monitoring due to comorbidity status:

  • Patients with pre-existing cardiac, renal, or hepatic disease due to the labeled risk of edema and potential congestive heart failure.
  • Patients with Uncontrolled Hypertension (use is generally not recommended).
  • Geriatric patients (Aged 65 and Older) require monitoring for prostatic changes as long-term safety data is limited.
Advertisements

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile for Testoviron-Depot, containing testosterone enanthate, is strictly based on documented patterns found in regulatory information, involving changes in drug exposure or additive pharmacological effects.

Drug-Drug Interactions

  • Oral Anticoagulants: Co-administration with oral anticoagulants, such as Warfarin, may increase anticoagulant activity. This change necessitates more frequent monitoring of the International Normalized Ratio (INR) and prothrombin time when beginning or stopping testosterone therapy.
  • Antidiabetic Agents: Androgens may cause a decrease in blood glucose levels. Patients using Insulin or oral antidiabetic medicines may require a reduction in the dose of their diabetes medicine to manage this effect.
  • Corticosteroids and ACTH: Concurrent use with corticosteroids or Adrenocorticotrophic Hormone (ACTH) may result in increased fluid retention (edema) due to an additive effect. This risk warrants particular caution in individuals with pre-existing cardiac, renal, or hepatic disease.
  • Enzyme Inducers: Substances classified as microsomal enzyme inducers, such as Barbiturates, can potentially increase the clearance of testosterone through a pharmacokinetic interaction, thereby decreasing its exposure.
  • Other Interactions: Testosterone may lead to increased serum levels of Oxyphenbutazone. Additionally, co-administration with other medications known to increase blood pressure may lead to an additive increase in blood pressure.
Advertisements

Mechanism of Action

Action via Genomic and Non-Genomic Receptor Signaling

The mechanism of action is mediated by Testosterone and its metabolite, Dihydrotestosterone (DHT), which function as agonists of the intracellular Androgen Receptor (AR). Agonist binding initiates a genomic signaling pathway where the hormone-receptor complex enters the cell nucleus to modulate gene expression, resulting in changes to protein synthesis. Concurrently, faster non-genomic signaling occurs through membrane ARs, triggering rapid second messenger cascades (e.g., MAPK/ERK) that cause immediate functional changes in the cell. This dual approach supports the core anabolic and structural mechanisms of the hormone.

Metabolic Interconversion and Systemic Synergy

The physiological action involves the drug's role as an enzymatic substrate. Testosterone is metabolized by 5alpha-Reductase into DHT, and by Aromatase (CYP19A1) into the estrogen, Estradiol ( E2). The coordinated action of these three molecules ensures a broad range of receptor activation: T and DHT activate the AR for androgenic responses, and E2 acts on Estrogen Receptors (ERs) to influence skeletal homeostasis, specifically Bone Mineral Density (BMD). The overall action modulates a broad range of receptor-mediated hormonal functions.

⬇️ Constraints via Plasma Protein Binding

Mechanism execution is physiologically constrained by Sex Hormone Binding Globulin (SHBG) in the plasma. SHBG binds a large portion of the hormone, rendering it inactive and unable to access the AR target. Therefore, the functional capacity of the mechanism—the degree of gene expression and resulting physiological change—is directly determined by the concentration of free, unbound Testosterone available to initiate the signaling cascade.

Advertisements

Dosage and Administration Information

Testoviron-Depot, which contains Testosterone Enanthate, is a long-acting injectable medicine used for testosterone replacement therapy in males with confirmed hypogonadism (testosterone deficiency). It is administered as a solution for intramuscular injection only and should never be given intravenously.

Administration and Dosage

  • Method: The injection must be given deeply into the gluteal muscle by a physician or trained healthcare professional. The injection should be administered very slowly to help prevent brief, rare reactions that can occur with oily solutions, such as a cough or shortness of breath.
  • Dosing: For adult male hypogonadism, an initial dose is 1 mL (equivalent to 250 mg Testosterone Enanthate) every two to three weeks. The specific dose and interval, however, must be individualized based on the patient's clinical picture and regular monitoring of their serum testosterone levels.

Monitoring and Safety

Before and during treatment, a doctor will perform careful and regular medical examinations. This typically includes ruling out prostate cancer and conducting annual or twice-yearly check-ups of the prostate gland and breast (in accordance with established methods), particularly in older or at-risk patients. In addition to monitoring serum testosterone, the following blood parameters are regularly checked: haemoglobin, haematocrit, and liver enzymes.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Testoviron-Depot (Testosterone)

Evidence for Use in Male Hypogonadism (Low Testosterone)

Key components of the research base for men with confirmed low testosterone (hypogonadism) include short-term Randomized Controlled Trials (RCTs), supported by systematic reviews and meta-analyses. These trials were typically applied in studies examining patient-reported experiences related to low energy, sexual function, and mood. Researchers focused on two main areas: monitoring serum testosterone levels and tracking symptomatic outcomes related to systemic or functional imbalance.

Studies monitored various outcomes reflecting daily functioning or activity level, including measures of libido, erectile function, depression scores, and quality of life. Research also examined physical characteristics, such as patterns related to lean mass versus fat mass, and monitored bone mineral density over the observed study periods.

Studies in Specific Populations: Adolescents and Older Adults

Research has explored the use of testosterone injections in populations beyond the typical adult male hypogonadism patient. Small-scale RCTs and evidence supporting clinical guidelines have been applied in studies examining adolescent males with confirmed delayed puberty. These studies monitored key developmental outcomes, including measuring pubertal characteristics and tracking the linear growth rate (how fast a boy is growing).

In addition to adolescents, data for certain groups remain insufficient, particularly for the very elderly male population (aged 75 and over). While some studies included older participants, the results apply only to the populations studied, and dedicated, large-scale controlled research in this specific age group is limited.

Evidence Gaps and Areas of Uncertainty

A major limitation is that long-term outcomes are not fully established, particularly concerning systemic health endpoints beyond the immediate symptoms studied. Long-term controlled data that help contextualize safety patterns over many years are limited. The evidence quality varies across studies, and many older trials have been deemed to have methodological weaknesses. This means that while research provides context, it does not determine whether an individual will respond similarly, and certainty remains low in certain areas.

Key Studies & References

  1. Testosterone Enanthate Injection, USP (Prescribing Information / Label)
  2. Cleveland Clinic-Led Trial Finds Testosterone-Replacement Therapy Does Not Increase Incidence of Major Adverse Cardiac Events for Men with Low Testosterone (TRAVERSE Trial summary)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Testoviron-Depot (Testosterone) (FAQ)

Q: What is the main difference between Testoviron-Depot and other testosterone injections?

A: Official documents describe Testoviron-Depot as containing testosterone enanthate, an esterified component dissolved in an oil vehicle. This composition is designed to create a long-lasting depot at the injection site. This system allows for the slow and sustained release of the hormone into the bloodstream over several weeks, which is the key feature distinguishing it from other injectable forms.


Q: Is Testoviron-Depot the same as testosterone enanthate?

A: Testoviron-Depot is a brand name medication. According to official labeling, its active ingredient is testosterone enanthate, which is the synthetic form of the hormone responsible for the drug’s therapeutic effect. The term 'Testosterone Enanthate' may also refer to the generic product containing the same active substance.


Q: How is Testoviron-Depot different from a testosterone gel or patch?

A: Testoviron-Depot is an oily solution administered as an intramuscular depot injection, which provides a slow, prolonged release of the hormone. In contrast, testosterone gels or patches are topical products applied to the skin. These topical formulations generally provide a more continuous, daily release of the hormone.


Q: Can Testoviron-Depot affect fertility in men?

A: Regulatory documents indicate that the use of testosterone may cause a reversible decrease in the number of sperm (male reproductive cells) produced. This effect is specifically noted in safety information, particularly when the medicine is used at higher doses. This is a topic typically subject to patient monitoring.


Q: Is there a link between Testoviron-Depot and an enlarged prostate?

A: Official safety documents list potential adverse reactions involving the prostate. These include prostatic changes such as benign prostatic hyperplasia (BPH), which is the non-cancerous enlargement of the prostate gland. Regular monitoring of the prostate is a standard part of treatment, especially for older patients.


Q: How long does the testosterone level stay elevated after one dose of Testoviron-Depot?

A: The active ingredient, testosterone enanthate, is slowly released from the injection site to maintain hormone levels for an extended period. Pharmacokinetic data indicates that the active levels are typically maintained for approximately two to three weeks, which corresponds to the usual recommended dosing interval.


Q: How quickly can a person expect to notice any changes after starting Testoviron-Depot?

A: Studies cited in authoritative resources indicate that the onset of effects varies for different outcomes. Changes related to mood or physical function may begin to be noticeable in as little as three to six weeks, but significant improvements often occur over several months of continued treatment.


Q: Is it true that Testoviron-Depot is a long-acting testosterone formulation?

A: Yes, Testoviron-Depot is classified in official documents as a long-acting injectable formulation. This is achieved because the active ingredient, testosterone enanthate, is slowly released from an oil depot, extending its effect over a longer time compared to immediate-release forms.


Q: Does Testoviron-Depot affect sleep patterns or cause insomnia?

A: Yes, regulatory safety information includes potential effects on sleep. Specifically, reported side effects associated with testosterone injection use include difficulty falling asleep or staying asleep (insomnia) and difficulty breathing, especially during sleep (sleep apnea).


Q: Can Testoviron-Depot cause hair loss or affect existing hair conditions?

A: Official safety data lists male pattern baldness (alopecia) as a possible dermatological side effect. Changes in body and facial hair growth (hirsutism) have also been reported in official documents.


Q: Is Testoviron-Depot considered a controlled substance?

A: Yes, regulatory documents confirm that the active ingredient, testosterone enanthate, is classified as a Schedule III controlled substance in jurisdictions like the United States. This classification is due to the potential for abuse and dependence.


Q: Can women legally or medically be prescribed Testoviron-Depot for any condition?

A: While use is generally restricted in women, official documents confirm conditional use is allowed for highly specific medical conditions. This includes the palliative (symptom-relieving) treatment of certain types of hormone-responsive mammary cancer.


Q: Does Testoviron-Depot affect mood or cause irritability?

A: Yes, official safety data lists changes in mental state and mood as reported side effects. These include mood swings, irritability, anxiety, and in some cases, depression or emotional lability.


Q: What is the purpose of the oil or vehicle used in the Testoviron-Depot injection?

A: The oil vehicle is used primarily to dissolve the testosterone ester and allow it to be injected into the muscle. The oil then facilitates the formation of a localized depot at the injection site, which is essential for the slow and controlled release of testosterone over an extended period.


Q: Are the effects of Testoviron-Depot permanent after stopping treatment?

A: Clinical trials cited in authoritative resources suggest that many of the observed physical and metabolic changes from testosterone treatment are reversible once the medicine is stopped. The degree and speed of reversibility may vary among individuals.


Q: What are the official regulatory uses of Testoviron-Depot in countries like the US or UK?

A: The official regulatory use is strictly for testosterone replacement therapy in males who have confirmed conditions associated with hypogonadism. This includes primary hypogonadism (testicular failure) or hypogonadotropic hypogonadism (pituitary/hypothalamic failure).


Q: Can taking Testoviron-Depot affect cholesterol levels or heart health?

A: Official documents state that testosterone use may affect serum lipid profiles, including a potential decrease in High-Density Lipoprotein (HDL) cholesterol. It is also associated with cardiovascular risks such as hypertension (high blood pressure) and thromboembolism (blood clots).


Q: What information is available about Testoviron-Depot and its effect on bone density?

A: Studies cited in the research base have shown that testosterone treatment can influence skeletal health. For men with confirmed hypogonadism, therapy can help to improve or maintain bone mineral density (BMD).


Q: Does Testoviron-Depot interact with alcohol?

A: While the combination is generally discouraged without specific medical review, some governmental medical sources state that the consumption of small amounts of alcohol does not appear to affect the safety or usefulness of testosterone enanthate. Information on alcohol consumption should be reviewed with a healthcare provider.


Q: Is it common to experience soreness or redness at the injection site after Testoviron-Depot?

A: Yes, official safety information lists injection site reactions as a common side effect. This frequently includes experiencing symptoms such as localized pain, redness (erythema), burning, or induration (hardness) at the site where the medicine was administered.


Q: Does Testoviron-Depot have a peak effect time in the body?

A: Yes, official pharmacokinetic data confirms that after the intramuscular injection is administered, testosterone levels in the blood will peak (reach their highest concentration) before they gradually decline over the subsequent days.


Q: What is the chemical classification of Testoviron-Depot?

A: According to regulatory sources, the medicine is classified pharmacologically as an Androgen. Chemically, it is categorized as an Anabolic Steroid and a Synthetic Androgen Ester.


Q: What is the evidence regarding Testoviron-Depot and cardiovascular risks?

A: Official warnings note a potential link between testosterone use and serious cardiovascular events. These include an increased risk of myocardial infarction (heart attack), stroke, and venous thromboembolism (blood clots). Official warnings note that high caution and regular monitoring are advised for patients with pre-existing heart conditions.


Q: Are there official warnings about secondary exposure to Testoviron-Depot users (e.g., through skin contact)?

A: Official warnings about secondary exposure generally apply to topical testosterone products (gels and patches). For those forms, women and children must strictly avoid contact with the application site due to the risk of virilization (developing male characteristics).


Q: Does the vehicle oil (like castor oil) in Testoviron-Depot cause issues?

A: Official documents state that the injection of the oily solution may cause rare, temporary breathing problems due to the presence of oil micro-embolism during administration. The formulation also requires caution for patients with a known hypersensitivity to the specific oil used as the vehicle.


Q: Is it true that Testoviron-Depot is banned in sports competitions?

A: Yes, testosterone and its synthetic derivatives, including testosterone enanthate, are classified as Prohibited Substances by global anti-doping organizations like the World Anti-Doping Agency (WADA). They are banned due to their performance-enhancing and anabolic effects.


Q: How does Testoviron-Depot affect the body's natural testosterone production?

A: Testosterone treatment can suppress the body's natural production of the hormone. This occurs by interfering with the hormonal signals from the pituitary gland. This suppression can potentially lead to conditions such as testicular atrophy.


Q: Are there any specific mental health side effects mentioned in the drug's profile?

A: Yes, psychiatric side effects reported in the official drug profile include rapidly changing moods (e.g., euphoria or paranoia), irritability, anxiety, and in some instances, major depression.


Q: What are the signs of a serious allergic reaction to Testoviron-Depot?

A: Official documents list signs of a severe allergic reaction (anaphylaxis). These can include hives, rash, blistering, swelling of the lips or tongue, or difficulty breathing.


Q: Are there different brands that make a drug similar to Testoviron-Depot?

A: Yes, the active ingredient, testosterone enanthate, is available under multiple brand names and is also manufactured as a generic product. This is typical for established medicines.


Q: Is the Testoviron-Depot injection painful?

A: Official safety documents list pain and other reactions at the injection site as a common side effect. This indicates that some level of localized discomfort is frequently reported by users.


Q: What is the legal status of Testoviron-Depot prescription worldwide?

A: Testoviron-Depot is a prescription-only medicine in all regulated jurisdictions, including the US, EU, and Canada. It can only be obtained with a valid prescription from a licensed healthcare provider.

Advertisements

How should Testoviron-Depot (Testosterone) be stored and disposed of?

Storage and Disposal Requirements

The storage and disposal of Testoviron-Depot (testosterone enanthate oily solution for injection) must strictly follow the requirements detailed in the official regulatory labeling.

Classification Requirement
Storage Temperature Store the product below 30 C.
Light Protection Must be protected from light and kept in the original package.
Child Safety Keep the medicine out of the sight and reach of children.
Environmental Disposal Do not throw away via wastewater or household waste.
Disposal Method Unused or expired medicine must be returned to a pharmacist or disposed of according to local requirements.

These mandated conditions ensure the stability of the oily solution and comply with public safety and pharmaceutical waste handling standards. The solution must be visually inspected prior to use and may only be used if it is clear and free from particles.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Testoviron-Depot (Testosterone) found in:

A-Z Index: